Status:
NOT_YET_RECRUITING
Digital Inhaler Use in Obstructive Lung Disease Care
Lead Sponsor:
Cedars-Sinai Medical Center
Collaborating Sponsors:
Breathe California, Los Angeles County
Conditions:
Chronic Obstructive Airways Disease Exacerbated
Chronic Obstructive Airway Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a pilot study to evaluate the role digital inhaler technology on patients with obstructive lung disease in preventing admissions and exacerbation, as well as improving symptom control. The pri...
Eligibility Criteria
Inclusion
- Any sex
- Over the age of 18 years.
- Physician-diagnosed obstructive lung disease
- Speak, read, and understand English.
- The current study is a feasibility pilot. Based on the results of the study, future studies will include non-English speakers as well.
- Able to understand study requirements and comply with study procedures.
- Ability to operate a smartphone or tablet (for questionnaire and symptoms input).
- Patients who use either a DPI or an MDI device as controller medications. Medications will not be changed by the study team.
Exclusion
- Physically disabled such that they are incapable of using digital devices or metered dose inhalers.
- Suffer from any visual, hearing or cognitive impairment that cannot be corrected enough to operate the devices properly. Mild/moderate vision loss and mild hearing loss may be included with appropriate corrective measures that do not affect the device usage.
- Suffering from serious uncontrolled medical conditions that may interfere with study conduct.
- Inability or unwillingness of the participant to give written informed consent.
- Pregnant women (due to complicated physiology)
- The current study is a feasibility pilot. Based on the results of the study, future studies will likely include pregnant patients as well.
- Prisoners
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07214337
Start Date
November 1 2025
End Date
June 1 2027
Last Update
October 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048